40% of diabetics have "serious difficulties" to control their glucose levels
Madrid, Sep. 22 (Europa Press) -
More than a third of people with diabetes breaches the treatment with insulin prescribed by their doctor or, at least, some dose is skipped, according to the results of the global attitudes survey of patients and doctors with insulin therapy (GAPP), carried out by Novo Nordisk, presented at the Congress of the European Association of Diabetes, which is celebrated these days in Stockholm (Sweden).
In addition, these patients who do not meet their treatment also recognize that these forgetfulness usually occur at least three times a month, although professionals believe that the figure could reach six monthly doses.
The study participated about 3,000 people from eight countries, including Spain, and the results also demonstrate that 88 percent of doctors believe that there is a very significant number of patients who do not reach optimal blood glucose figures.
In fact, they say that 40 percent of diabetes patients have "serious difficulties" to control their blood glucose levels, in line figures with the results obtained in previous research, which already demonstrated that only half of those affectedFor this disease they have an optimal state of health and quality of life.
According to the associated director at the Diabetes Research Institute of the University of Miami (USA), Luigi Meneghini, "it seems that today's lifestyle and the difficulty in properly fulfillthe low control of the glycemic level. "
In fact, both patients and doctors recognize that changes in daily routine, stress or a simple oblivion are the main reasons that explain this high degree of therapeutic breach.
More than half of the specialists agree that their patients have difficulties in terms of injections, due to the strict therapies.
Less invasive therapies
On the other hand, the survey has also shown that nine out of ten patients (90%) would like to have an insulin that could be administered less frequently than the current one, which is used once a day.
In addition, 67 percent of them believe that the disease controls their lives since they started this treatment.As for specialists, research indicates that a third of these is dissatisfied with the possibility of adapting patient lifestyle treatments.
